KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Net Income towards Common Stockholders: 2009-2014

Historic Net Income towards Common Stockholders for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -$50.7 million.

  • Biocryst Pharmaceuticals' Net Income towards Common Stockholders fell 11.36% to -$14.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$42.2 million, marking a year-over-year decrease of 0.88%. This contributed to the annual value of -$50.7 million for FY2014, which is 43.14% down from last year.
  • According to the latest figures from FY2014, Biocryst Pharmaceuticals' Net Income towards Common Stockholders is -$50.7 million, which was down 43.14% from -$35.4 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Net Income towards Common Stockholders ranged from a high of -$33.9 million in FY2010 and a low of -$52.9 million during FY2011.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$38.3 million (2012), whereas its average is -$41.5 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 151.68% in 2010, then grew by 27.60% in 2012.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Net Income towards Common Stockholders stood at -$33.9 million in 2010, then plummeted by 56.41% to -$52.9 million in 2011, then increased by 27.60% to -$38.3 million in 2012, then grew by 7.64% to -$35.4 million in 2013, then crashed by 43.14% to -$50.7 million in 2014.